US FDA approves KalVista Pharma’s swelling disorder drug, shares rise
By Puyaan Singh (Reuters) -KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the ...
Read moreDetailsTag: hereditary angioedema
Recent News
